![Pfizer/BioNTech COVID-19 booster 95.6% effective against disease: study](https://cdn.newsserve.net/en/knowledge/Pfizer_20190121.jpg)
Pfizer/BioNTech COVID-19 booster 95.6% effective against disease: study
A 30-microgram booster dose showed a relative vaccine efficacy of 95.6% in individuals who had previously received the Pfizer/BioNTech primary two-dose series, the companies announced.
Full Article